Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine effects on hypoxic ventilatory response in healthy volunteers
NL-OMON60776Phase 4Completed
- Sponsor
- Leiden University Medical Center
- Start
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of esketamine (2 arms), sponsored by Leiden University Medical Center. Primary endpoint: Hypoxic ventilatory response. Started Aug 2023; status: completed.
02
Drugs
esketamine
Beyond the preview
Go deeper on NL-OMON60776.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON60776.